Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer

• Abderrahim El Guerrab,

  Affiliations Department of Oncogenetic, Centre Jean Perrin, Clermont-Ferrand, France, ADELBIO, Faculty of Medicine, Centre Biomédical de Recherche et Valorisation, Clermont-Ferrand, France

  ⨯
• Rabah Zegrour,

  Affiliation ADELBIO, Faculty of Medicine, Centre Biomédical de Recherche et Valorisation, Clermont-Ferrand, France

  ⨯
• Carine-Christiane Nemlin,

  Affiliation ADELBIO, Faculty of Medicine, Centre Biomédical de Recherche et Valorisation, Clermont-Ferrand, France

  ⨯
• Flavie Vigier,

  Affiliation ADELBIO, Faculty of Medicine, Centre Biomédical de Recherche et Valorisation, Clermont-Ferrand, France

  ⨯
• Anne Cayre,

  Affiliation Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France

  ⨯
• Frederique Penault-Llorca,

  Affiliation Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France

  ⨯
• Fabrice Rossignol,

  Affiliation ADELBIO, Faculty of Medicine, Centre Biomédical de Recherche et Valorisation, Clermont-Ferrand, France

  ⨯
• Yves-Jean Bignon

  * E-mail: Yves-Jean.BIGNON@cjp.fr

  Affiliation Department of Oncogenetic, Centre Jean Perrin, Clermont-Ferrand, France

  ⨯